Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novasep makes management appointments

This article was originally published in Scrip

Executive Summary

Novasep (France), a supplier of manufacturing solutions to the life sciences industries, has named Stephen Stefano president and CEO of Novasep North American business, and Patrick Glaser president and CEO of the Novasep synthesis division, a newly created position. They will both also join Groupe Novasep's executive management committee. Mr Stefano was formerly senior vice-president at GlaxoSmithKline Pharmaceuticals, where he was responsible for business development for North America and new product planning. Mr Glaser was most recently vice-president of Dr Reddy's Laboratories' active pharmaceutical ingredient business.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC008702

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel